Abstract

Background: In October of 2015, an epidemic of Zika began in Colombia's geographic areas with a high population of mosquitoes of the genus Aedes. Our aim was to describe the outcome of fetuses of symptomatic pregnant women who were tested with RT-PCR for ZIKV according to trimester of infection. Methods: Symptomatic women were tested with RT-PCR for ZIKV and followed prospectively by obstetricians and high-risk maternal-fetal medicine specialists, using detailed anatomic ultrasound and neurosonography to detect fetal structural anomalies of the central nervous system (CNS) according to trimester of infection. Findings: 115 symptomatic women with a positive RT-PCR and 56 with a negative RT-PCR were enrolled in the study; CNS compromise of the fetus occurred in 24% and 20%, respectively (p=0.398). When symptomatic ZIKV positive women were categorized by trimester of infection, CNS anomalies were present in 38% of first-trimester infections, compared to 21% and 10% in second and third-trimester infections (p=0.012). Including all trimesters, neuronal migration disorders were the most frequent anomaly of the CNS (15%), followed by microcephaly (13%). Interpretation: Prevalence of CNS anomalies were similar between symptomatic RT-PCR ZIKV positive and negative pregnant women suggesting a high rate of false-negative results with RT-PCR. First-trimester infections were more frequent and severe compared to second and third-trimester infections in exposed fetuses. The prevalence of CNS anomalies was higher than previously reported in the literature, possibly due to fetal-ultrasound assessments' quality and expertise. Migrational disorders were the most frequently observed anomaly of the CNS, followed by microcephaly. Funding: Grants from the Universidad Industrial de Santander (UIS), and the Epidemiology Research Center at UIS, supported this study. Conflict of Interest: We declare no competing interests. Ethical Approval: The Committee on Ethics and Research from the Universidad Industrial de Santander and participating centers approved the study. All pregnant women signed informed consent for participation in this study.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.